Hot Topics in Diabetes and Endocrinology for Primary Care
The California Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.
This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.
Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.
Family Practice, Internal Medicine Physicians, Nurse Practitioners, Physician Assistants and other health care professionals interested in the treatment of diabetes and other common endocrine diseases living in and around Santa Rosa, CA.
- After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and current healthcare practices.
- How to implement the 2018 AACE Diabetes Algorithm into your practice
- Evaluating options with focus on incorporating SGLT2 Inhibitors and GLP-1ra's into therapy
- Recognize when advanced Beta Cell failure is present and basal insulin is necessary
- Know when the newer basal insulin formulations are indicated and how to use these with other agents such as GLP-1 agonists
- Incorporate the newest methods to collect and interpret blood glucose data in your practice
- Identify key components in evaluating the ambulatory glucose profile in order to minimize glucose variability and hypoglycemia of patients with diabetes
- Discuss current DM medications with proven CV risk reduction independent of glucose lowering
- Is time to look beyond glycemic control?
- Introduce the New AACE Lipid Guidelines
- Incorporate new agents to lower LDL cholesterol into a treatment paradigm
- Identify key components of thyroid function studies in different clinical situations
- Understand the values and pitfalls of Thyroid Ultrasound and thyroid Scan
- At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
June 9, 2018
|7:00 – 7:45 AM|
Breakfast / Registration
|7:45 - 8:00 AM|
Welcome & Pre-Meeting Assessment
|8:00 – 8:30 AM||AACE Diabetes Algorithm-with Focus on SGLT2 Inhibitors and GLP-1 Therapies |
Jaiwant Rangi, MD, FACE
|8:30 – 9:00 AM||Insulin Initiation and Intensification with Focus on Hypoglycemia Reduction |
Karen Earle, MD
|9:00 – 9:30 AM||Incorporating CGM into Clinical Decision Making |
Etie Moghissi, MD, FACP, FACE
|9:30 – 10:00 AM||Cardiovascular Outcome Studies, Is It Time for Paradigm Shift? |
David Chappell, MD
|10:00 – 10:15 AM|
|10:15 – 10:45 AM|
|10:45 – 11:15 AM||Management of Hyperlipidemia Beyond Statins |
Chris Guerin, MD, FACE
|11:15 – 11:45 PM||Thyroid Conundrums |
Joseph Hawkins, Jr. MD, FACE
|11:45 – 12:15 PM|
|12:15 – 12:45 PM|
Post Meeting Assessment
David A. Chappell, MD
Karen Earle, MD
Chief of Endocrinology, California Pacific Medical Center
Medical Director, Center for Diabetes Services, CPMC
Assistant Program Director, Endocrinology Fellowship, CPMC
Division Chief, Medical and Surgical Subspecialties, Sutter West Bay Medical Foundation
San Francisco, CA
*Chris K. Guerin, MD, FACE
Assistant Clinical Professor of Medicine
University of California, San Diego
Joseph Hawkins, Jr., MD, FACE
Sierra Endocrine Associates
*Etie Moghissi, MD, FACP, FACE
Clinical Associate Professor
University of California Los Angeles
Marina del Rey, CA
Jaiwant Rangi, MD, FACE
Cameron Park, CA
*Indicates individual is also a member of the program committee
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the California Chapter of AACE. AACE is accredited by the ACCME to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.50 AMA
- 4.50 Attendance